H. Yamaga

Variations in ORAI1 Gene Associated with Kawasaki Disease

Toshihiro Tanaka, K. Ozaki, T. Hara, 2016, PloS one.

Cyclosporin A Treatment for Kawasaki Disease Refractory to Initial and Additional Intravenous Immunoglobulin

A. Hata, N. Yoshikawa, Yoichi Suzuki, 2011, The Pediatric infectious disease journal.

Analysis of Age, Sex, Lack of Response to Intravenous Immunoglobulin, and Development of Coronary Artery Abnormalities in Children With Kawasaki Disease in Japan

Nobuyuki Kakimoto, N. Kitano, Hiroyuki Suzuki, 2022, JAMA network open.

Inflammatory cytokine profiles during Cyclosporin treatment for immunoglobulin-resistant Kawasaki disease.

Jun Abe, Norishige Yoshikawa, A. Hata, 2012, Cytokine.

A genome-wide association study identifies three new risk loci for Kawasaki disease

Yusuke Nakamura, Tatsuhiko Tsunoda, Kouichi Ozaki, 2012, Nature Genetics.

ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease

T Tanaka, Toshihiro Tanaka, K. Ozaki, 2011, The Pharmacogenomics Journal.